Ravi S. N. Munuganti

Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1<i>H</i>-benzimidazole Derivatives

Ravi S. N. Munuganti, Eric Leblanc, Peter Axerio-Cilies et al. · Journal of Medicinal Chemistry · 2013 · 89 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer

Ravi S. N. Munuganti, Mohamed D.H. Hassona, Eric Leblanc et al. · Chemistry & Biology · 2014 · 66 citations

Medicine, Oncology, Pharmacology +17

Discovery of 1<i>H</i>-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)

Fuqiang Ban, Eric Leblanc, Huifang Li et al. · Journal of Medicinal Chemistry · 2014 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition

Kirsi Ketola, Ravi S. N. Munuganti, Alastair Davies et al. · Clinical Cancer Research · 2017 · 46 citations

Medicine, Oncology, Pharmacology +17

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Fraser Johnson, John R. Ferrarone, Alvin Liu et al. · Cell Reports · 2022 · 30 citations · Full text

Life Sciences, Molecular Biology, Oncology +16